These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Metabolic fate of the new cardiotonic denopamine in animals. 2nd communication: tissue accumulation in the rat after consecutive oral administration of 14C-denopamine. Naito K, Furuuchi S, Usuki S, Otsuka M, Harigaya S. Arzneimittelforschung; 1986 Apr; 36(4):652-5. PubMed ID: 3718589 [Abstract] [Full Text] [Related]
6. Pharmacological analysis of positive chrono- and inotropic responses to denopamine (TA-064) in dog cross-circulated atrial and ventricular preparations. Akahane K, Furukawa Y, Karasawa Y, Ren LM, Chiba S. Jpn J Pharmacol; 1990 Jan; 52(1):69-79. PubMed ID: 1968521 [Abstract] [Full Text] [Related]
7. Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs. Ikeo T, Nagao T, Suzuki T, Yabana H, Nakajima H. Jpn J Pharmacol; 1985 Oct; 39(2):191-9. PubMed ID: 4087566 [Abstract] [Full Text] [Related]
13. Effect of chronic administration of denopamine (TA-064), a new positive inotropic agent, on cardiac response of rats to denopamine. Yabana H, Naito K, Nagao T. Jpn J Pharmacol; 1986 Sep; 42(1):87-97. PubMed ID: 3795620 [Abstract] [Full Text] [Related]
14. Effect of denopamine on the phosphorylation of cardiac muscle proteins in the perfused guinea-pig heart. Comparison with isoproterenol. Sasaki Y, Yabana H, Nagao T, Takeyama S. Biochem Pharmacol; 1988 Feb 15; 37(4):679-86. PubMed ID: 2829921 [Abstract] [Full Text] [Related]
17. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors. Suzuki T, Nantel F, Bonin H, Valiquette M, Bouvier M. J Pharmacol Exp Ther; 1993 Nov 15; 267(2):785-90. PubMed ID: 7902433 [Abstract] [Full Text] [Related]
19. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure. Hauf GF, Bubenheimer P, Roskamm H. Arzneimittelforschung; 1981 Nov 15; 31(1a):253-6. PubMed ID: 7195235 [Abstract] [Full Text] [Related]